INSIGHTS ON CLINICAL TRIAL DESIGN

• Advancing Alzheimer's Disease Therapies

  By uniting scientific innovation with patient-focused execution, the next generation of alzheimer’s disease (AD) therapies has the potential to deliver a transformative impact on global health.

• Cell And Gene Therapy For Enhanced CNS And Ocular Delivery In Nonhuman Primates

  Gain valuable insights into the cutting-edge approaches shaping the future of gene and cell therapy delivery, ensuring more effective and efficient translation from discovery to clinical application.

• The Complexities Of Effective Patient Retention In Clinical Trials

  Identifying and enrolling the right-fit patients from the outset is essential, but so is implementing comprehensive retention strategies that prioritize patient comfort, trust, and ongoing engagement.

• Patient Trust And Engagement In The Age Of Decentralized Trials

  To truly maximize enrollment in decentralized models, sponsors must invest in human connection to build the trust needed to move patients from awareness to active participation.

• Change Needed In Approach To Clinical Trials Patient Recruitment

  8/20/2026

  Drawing on real-world experience and end-to-end capabilities, this presentation outlines actionable strategies to accelerate recruitment, boost predictability, and expand patient trial access.

• When "Everything" Is The Pain Point: Rethinking RTSM For Real-World Use

  7/30/2026

  RTSM friction often comes from complexity, limited flexibility, and siloed data. Discover approaches that improve visibility, forecasting, and operational efficiency across clinical trials.

• How Adaptive Design Accelerates Early‑Phase NSCLC Development

  5/22/2026

  Adaptive trial designs and an adaptive mindset enable non-small cell lung cancer (NSCLC) sponsors to optimize dose, respond to evolving expectations, and accelerate early‑phase development.

• The Rapid Digitization Of Trials

  11/7/2024

  It’s no secret that more trials are going digital. Hear from a panel of industry experts including Sanofi, Bayer, and the Clinical Trials Transformation Initiative (CTTI) as they discuss the evolution of digital trials and share their experiences.

• On-Demand Service Models Improve Clinical Trials

  12/8/2025

  As consumers increasingly expect convenience and immediacy, the on-demand model continues to reshape how services are delivered across nearly every sector.